These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 28392558)
1. The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective. Junghans RP Cancer Gene Ther; 2017 Mar; 24(3):89-99. PubMed ID: 28392558 [No Abstract] [Full Text] [Related]
2. Next Steps in the CAR Journey of a Thousand Miles. Brenner MK Mol Ther; 2017 Oct; 25(10):2226-2227. PubMed ID: 28939089 [No Abstract] [Full Text] [Related]
3. Celyad's novel CAR T-cell therapy for solid malignancies. Lonez C; Hendlisz A; Shaza L; Aftimos P; Vouche M; Donckier V; Machiels JH; Van Den Eynde M; Canon JL; Carrasco J; Odunsi K; Sahebjam S; Rottey S; Braun N; Verma B; Gilham DE; Lehmann FF Curr Res Transl Med; 2018 May; 66(2):53-56. PubMed ID: 29625833 [TBL] [Abstract][Full Text] [Related]
4. Recent perspective on CAR and Fcγ-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes. Marei HE; Althani A; Caceci T; Arriga R; Sconocchia T; Ottaviani A; Lanzilli G; Roselli M; Caratelli S; Cenciarelli C; Sconocchia G Biochem Pharmacol; 2019 Aug; 166():335-346. PubMed ID: 31176617 [TBL] [Abstract][Full Text] [Related]
5. Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors. Zhang E; Gu J; Xu H Mol Cancer; 2018 Jan; 17(1):7. PubMed ID: 29329591 [TBL] [Abstract][Full Text] [Related]
7. Driving CARs Across New Borders. Turtle CJ; Adair JE Hum Gene Ther; 2018 May; 29(5):529. PubMed ID: 29715075 [No Abstract] [Full Text] [Related]
8. An Interview with Michel Sadelain, MD, PhD. Adair JE Hum Gene Ther; 2018 May; 29(5):530-533. PubMed ID: 29715074 [No Abstract] [Full Text] [Related]
9. Immunotherapy: Tisagenlecleucel - the first approved CAR-T-cell therapy: implications for payers and policy makers. Prasad V Nat Rev Clin Oncol; 2018 Jan; 15(1):11-12. PubMed ID: 28975930 [No Abstract] [Full Text] [Related]
10. Challenges and prospects of chimeric antigen receptor T cell therapy in solid tumors. Jindal V; Arora E; Gupta S Med Oncol; 2018 May; 35(6):87. PubMed ID: 29730801 [TBL] [Abstract][Full Text] [Related]
11. Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects. Di S; Li Z Sci China Life Sci; 2016 Apr; 59(4):360-9. PubMed ID: 26968709 [TBL] [Abstract][Full Text] [Related]
12. Chimeric antigen receptor macrophage for glioblastoma immunotherapy: the way forward. Gatto L; Nunno VD; Franceschi E; Brandes AA Immunotherapy; 2021 Aug; 13(11):879-883. PubMed ID: 34078139 [No Abstract] [Full Text] [Related]
13. Chimeric antigen receptor-engineered T-cell therapy for liver cancer. Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325 [TBL] [Abstract][Full Text] [Related]
14. CAR T Cell Therapy for Solid Tumors. Newick K; O'Brien S; Moon E; Albelda SM Annu Rev Med; 2017 Jan; 68():139-152. PubMed ID: 27860544 [TBL] [Abstract][Full Text] [Related]
15. EEG findings in CAR T-cell therapy-related encephalopathy. Herlopian A; Dietrich J; Abramson JS; Cole AJ; Westover MB Neurology; 2018 Jul; 91(5):227-229. PubMed ID: 29959264 [No Abstract] [Full Text] [Related]
16. The trials and tribulations of CAR-T cell development for cancer and AIDS. Hege K Nat Med; 2019 Aug; 25(8):1183. PubMed ID: 31388173 [No Abstract] [Full Text] [Related]
17. Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T Cells. Abken H Hum Gene Ther; 2017 Nov; 28(11):1047-1060. PubMed ID: 28810803 [TBL] [Abstract][Full Text] [Related]
18. Chimeric antigen receptor transduced T cells: Tuning up for the next generation. Schubert ML; Hoffmann JM; Dreger P; Müller-Tidow C; Schmitt M Int J Cancer; 2018 May; 142(9):1738-1747. PubMed ID: 29119551 [TBL] [Abstract][Full Text] [Related]
19. Beginning the CAR T cell therapy revolution in the US and EU. Grupp S Curr Res Transl Med; 2018 May; 66(2):62-64. PubMed ID: 29656949 [No Abstract] [Full Text] [Related]
20. Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors. Jin C; Yu D; Essand M Immunotherapy; 2016 Dec; 8(12):1355-1361. PubMed ID: 28000533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]